Checkpoint Therapeutics (CKPT) Stock Chart & Stock Price History $4.26 0.00 (0.00%) As of 05/30/2025 Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Checkpoint Therapeutics Stock Price Performance The Checkpoint Therapeutics (CKPT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 125.40%, with a year-to-date return of 33.13%. In the past month, the stock has increased 2.65%, reflecting recent market activity. As of the latest close, Checkpoint Therapeutics traded at $4.26 with a market cap of $370.71 million and volume of 0 shares. Five years ago, the stock traded at a split-adjusted price of $19.90, representing a 78.59% decrease over that period. At the time, it had a market cap of $115.09 million and a volume of 28,500 shares. Receive CKPT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Checkpoint Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day PerformanceN/A1 Month Performance+2.65%3 Month Performance+72.47%Year-To-Date Performance+33.13%1 Year Performance+125.40%5 Year Performance-78.59% CKPT Stock Chart for Saturday, June, 7, 2025 CKPT Chart by TradingView Checkpoint Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/30/2025$4.26$4.29+0.61%$4.28$4.238.67 million shs$372.97 million05/29/2025$4.23$4.26+0.71%$4.28$4.238.63 million shs$370.71 million05/28/2025$4.19$4.23+0.95%$4.25$4.1912.19 million shs$368.10 million05/27/2025$4.19$4.19$4.19$4.183.21 million shs$350.97 million05/26/2025$4.19$4.19$4.19$4.162.31 million shs$350.97 million05/23/2025$4.17$4.19+0.48%$4.19$4.162.31 million shs$350.97 million05/22/2025$4.18$4.17-0.24%$4.20$4.163.21 million shs$349.30 million05/21/2025$4.16$4.18+0.48%$4.18$4.15507,967 shs$350.13 million05/20/2025$4.16$4.16$4.17$4.151.16 million shs$348.46 million05/19/2025$4.15$4.16+0.24%$4.17$4.15513,724 shs$348.46 million Get the Latest News and Ratings for CKPT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Checkpoint Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/16/2025$4.15$4.15$4.16$4.15276,805 shs$347.62 million05/15/2025$4.15$4.15$4.16$4.15855,701 shs$347.62 million05/14/2025$4.15$4.15$4.16$4.15637,488 shs$347.62 million05/13/2025$4.16$4.15-0.24%$4.17$4.14866,682 shs$347.62 million05/12/2025$4.16$4.16$4.18$4.16469,689 shs$348.46 million05/09/2025$4.15$4.16+0.36%$4.18$4.14790,826 shs$348.46 million05/08/2025$4.15$4.15-0.12%$4.16$4.14706,140 shs$347.20 million05/07/2025$4.15$4.15+0.12%$4.17$4.14929,902 shs$347.62 million05/06/2025$4.15$4.15-0.12%$4.15$4.14445,765 shs$347.20 million Related Companies Janux Therapeutics Stock Chart 89bio Stock Chart Adaptive Biotechnologies Stock Chart Dyne Therapeutics Stock Chart ARS Pharmaceuticals Stock Chart Evotec Stock Chart Travere Therapeutics Stock Chart ANI Pharmaceuticals Stock Chart Mesoblast Stock Chart Ocular Therapeutix Stock Chart Receive CKPT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Checkpoint Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CKPT) was last updated on 6/7/2025 by MarketBeat.com Staff From Our PartnersAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Checkpoint Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Checkpoint Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
